What You Should Know: - Ro announced it has acquired Workpath, a technology
platform that powers on-demand, in-home healthcare and diagnostics services
nationwide. - Through this acquisition, Ro’s platform will now
uniquely bring together a patient's doctor, pharmacy, and
diagnostics/lab--offering a personalized, end-to-end experience with no
insurance required. - Ro is also announcing a partnership with Quest
Diagnostics, which operates more than 2,200 locations nationwide, to
Read More
Clinical Trial
NLP is Raising the Bar on Accurate Detection of Adverse Drug Events
Each year, Adverse Drug Events (ADE) account for nearly 700,000 emergency department visits and 100,000 hospitalizations in the US alone. Nearly 5 percent of hospitalized patients experience an ADE, making them one of the most common types of inpatient errors. What’s more, many of these instances are hard to discover because they are never reported. In fact, the median under-reporting rate in one meta-analysis of 37 studies was 94 percent. This is especially problematic given the negative
Read More
Recent Executive Hires: CVS Health New President, Cleveland Clinic/Amwell Joint Venture Leadership, Others
CVS Health Corporation names Neela Montgomery Executive Vice President and President of CVS Pharmacy/Retail, effective November 30, 2020. Montgomery will oversee the company's 10,000 pharmacies across the United States. Montgomery, currently a Board Partner at venture capital firm Greycroft, most recently served as chief executive officer of furniture retailer Crate & Barrel and has nearly 20 years of global retail experience. The Cleveland Clinic and Amwell joint venture appoint
Read More
Study: Asthma Patients Maintain High Medication Adherence Using Propeller Health’s Platform
What You Should Know: - New study out from Propeller and Chicago's NorthShore
University HealthSystem shows that asthma patients maintain higher medication
adherence and decrease their rescue inhaler use when using a digital health
platform. - The study looked at 100 patients recruited from
NorthShore practices, half of whom used Propeller to manage their condition and
half of whom did not. - The treatment group maintained their high medication adherence at 68%, while the control
Read More
FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer
What You Should Know: - The FDA just extended its research collaboration
agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting
cancer. - With this expanded agreement, COTA and the FDA will use real-world data to explore the impact of COVID-19 and the pandemic on cancer treatment, with the opportunity to expand into other oncology questions in the future. COTA, Inc., a healthcare technology
company that uses real-world data to bring clarity to cancer care,
Read More
FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment
What You Should Know: - FDA awards AppliedVR Breakthrough Device designation for
treating treatment-resistant fibromyalgia and chronic intractable lower back
pain - AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR,
a pioneer advancing the next generation of digital medicine, today announced
its EaseVRx product received Breakthrough Device designation
Read More
Virta Adds Prediabetes and Obesity Reversal to Services
What You Should Know: - Virta is expanding its suite of treatment options to
include prediabetes reversal, obesity reversal, and type 2 diabetes management. - By making this crucial expansion, Virta can scale its
treatment to support the tens of millions of additional patients with
prediabetes and obesity, as provide an on-ramp to reversal for those with T2D
that aren’t yet ready to reverse. Virta Health, the
leader in type 2 diabetes reversal, today introduced the addition
Read More
Parexel Acquires Healthcare NLP Provider Roam Analytics
What You Should Know: - Parexel acquires healthcare software company Roam
Analytics, Inc. to strengthen and enhance Parexel’s pharmacovigilance (PV)
services. - The acquisition provides significant opportunities to
apply Roam Analytics’ natural language processing (NLP) technology to further
streamline and extract insights from unstructured data. - Parexel will also use Roam’s AI technology to leverage
various data, from clinical notes, medical images, patient surveys,
Read More
Medable Launches TeleConsent for Clinical Trials to Streamline Approvals During Decentralized Trials
What You Should Know: - Medable launches Teleconsent, part of its Telehealth
family of cloud-based software for decentralized clinical trials. - The application represents the next big step in
enabling fully virtual trials and is key to patient-centric trial design
because it allows patients to handle the lengthy process of consenting – and
re-consenting – to trial participation conveniently from anywhere. Medable Inc.,
a software provider for decentralized clinical trials,
Read More
Fitbit Awarded Regulatory Clearance in U.S. and Europe for ECG App to Identify AFib
What You Should Know: - Fitbit has received 510(k) clearance from the
FDA, as well as CE marking in the European Union, for its ECG
app to assess heart rhythm for atrial fibrillation. The Fitbit ECG App is a
simple way people can take an on-the-spot reading of their heart rhythm at any
time, including whenever they notice any unusual cardiac symptoms. - Fitbit Sense is the company’s first device compatible
with an ECG app that enables users to take a spot
Read More
